N 894 150 (Nizatidine 150 mg)
Pill with imprint N 894 150 is Brown & White, Capsule-shape and has been identified as Nizatidine 150 mg. It is supplied by Teva Pharmaceuticals USA.
Nizatidine is used in the treatment of gerd; duodenal ulcer; duodenal ulcer prophylaxis; erosive esophagitis; indigestion (and more), and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Nizatidine 150 mg is not a controlled substance under the Controlled Substance Act (CSA).
Images for N 894 150
Nizatidine
- Imprint:
- N 894 150
- Strength:
- 150 mg
- Color:
- Brown & White
- Size:
- 18.00 mm
- Shape:
- Capsule-shape
- Availability:
- Rx and/or OTC
- Drug Class:
- H2 antagonists
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Teva Pharmaceuticals USA
More about nizatidine
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 6 Reviews – Add your own review/rating
- Drug class: H2 antagonists
Consumer resources
Other brands: Axid, Axid AR, Axid Pulvules
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
